Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy

BACKGROUND: Oxaliplatin + S-1 is a recognized treatment regimen in Japan, but there are no Japanese clinical data on an oxaliplatin dose of 130 mg/m(2). The current research involves a single-arm, prospective, phase II clinical trial to examine the efficacy and safety of oxaliplatin + S-1 with an ox...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeki, Hiroshi, Emi, Yasunori, Oki, Eiji, Tokunaga, Shoji, Kakeji, Yoshihiro, Akagi, Yoshito, Baba, Hideo, Baba, Eishi, Maehara, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759242/
https://www.ncbi.nlm.nih.gov/pubmed/29310611
http://dx.doi.org/10.1186/s12885-017-3937-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759242/
https://www.ncbi.nlm.nih.gov/pubmed/29310611
http://dx.doi.org/10.1186/s12885-017-3937-6

Ejemplares similares